A bitter pill to swallow?

Article Abstract:

UK companies in April 2004 are focusing on the requirements of all European listed firms to adopt International Financial Reporting Standards (IFRS), and all the challenges that conversion to IFRS presents. The pharmaceutical sector faces issues such as research and development (R&D), product licensing and other revenue recognition matters, and would also be sensitive to general areas such as employee compensation and upcoming changes in accounting for mergers and acquisitions.

Author: Oxley, Stephen
Reporting & Disclosure, Financial statements

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


What FDs think

Article Abstract:

Finance directors are worried about the international accounting standard-setting process, but they also have the capacity to influence the creation of quality standards in future. Many research reports have revealed that the UK finance directors are ready to support the International Financial Reporting Standards (IFRS) convergence on their own terms.

Author: Dilks, Ian
Evaluation, Surveys, Accounting, Disclosure statements (Accounting), Accounting standards

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Big bath for pensions?

Article Abstract:

Retirement benefits may suffer under the new accounting standard, which companies have until Jun 03 to implement. Boots Co. PLC shifted its pension funds to bonds to avoid volatility.

Drug stores and proprietary stores, Pharmacies and Drug Stores, Drug Stores, Compensation and benefits, Accounting and auditing, Drugstores, Boots Company PLC, Retirement benefits

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Standards, United Kingdom, Accounting firms, Accounting services
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.